SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001171520-14-000675
Filing Date
2014-10-06
Accepted
2014-10-06 12:43:08
Documents
1
Group Members
BLACKBRIDGE CAPITAL, LLC

Document Format Files

Seq Description Document Type Size
1 eps5880.htm SC 13G 53695
  Complete submission text file 0001171520-14-000675.txt   55287
Mailing Address 4275 EXECUTIVE SQUARE, SUITE 200 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE, SUITE 200 LA JOLLA CA 92037 858-964-5123
INNOVUS PHARMACEUTICALS, INC. (Subject) CIK: 0001411879 (see all company filings)

IRS No.: 870324697 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87796 | Film No.: 141142291
SIC: 2834 Pharmaceutical Preparations

Mailing Address 450 7TH AVE SUITE 601 NEW YORK NY 10123
Business Address 450 7TH AVE SUITE 601 NEW YORK NY 10123 2126559604
Blackbridge Capital LLC (Filed by) CIK: 0001616538 (see all company filings)

IRS No.: 461044853 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G